Correspondence on "COVID-19 Related Anxiety in Men With Localized Prostate Cancer".
作者信息
Mungmunpuntipantip Rujittika, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Bangkok, Thailand.
121766Dr DY Patil University, Pune, India.
出版信息
Cancer Control. 2021 Jan-Dec;28:10732748211062343. doi: 10.1177/10732748211062343.
Abstract
摘要
相似文献
1
Correspondence on "COVID-19 Related Anxiety in Men With Localized Prostate Cancer".关于“局限性前列腺癌男性患者的 COVID-19 相关焦虑”的通信
Cancer Control. 2021 Jan-Dec;28:10732748211062343. doi: 10.1177/10732748211062343.
2
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2. Reply.
J Urol. 2021 Sep;206(3):785. doi: 10.1097/JU.0000000000001884. Epub 2021 May 17.
3
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. Letter.
J Urol. 2021 Sep;206(3):784-785. doi: 10.1097/JU.0000000000001883. Epub 2021 May 17.
4
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
5
Androgen deprivation and SARS-CoV-2 in men with prostate cancer.前列腺癌男性患者的雄激素剥夺与新型冠状病毒肺炎
Ann Oncol. 2020 Oct;31(10):1417-1418. doi: 10.1016/j.annonc.2020.06.015. Epub 2020 Jun 29.
6
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.雄激素剥夺疗法不会影响前列腺癌男性感染 SARS-CoV-2 的风险。
J Urol. 2021 Feb;205(2):441-443. doi: 10.1097/JU.0000000000001338. Epub 2020 Sep 8.
7
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry.前列腺癌男性患者的雄激素剥夺疗法与严重急性呼吸综合征冠状病毒2：来自加利福尼亚大学卫生系统登记处的研究结果
Ann Oncol. 2021 May;32(5):678-679. doi: 10.1016/j.annonc.2021.01.067. Epub 2021 Feb 8.
8
CD4 T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.前列腺癌患者的 CD4 T 细胞对源自 SARS-CoV-2 刺突糖蛋白的抗原的免疫反应降低。
Front Immunol. 2021 May 3;12:629102. doi: 10.3389/fimmu.2021.629102. eCollection 2021.
9
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.雄激素剥夺疗法与 COVID-19 大流行初始阶段男性前列腺癌患者的超额死亡率。
PLoS One. 2021 Oct 7;16(10):e0255966. doi: 10.1371/journal.pone.0255966. eCollection 2021.
10
Prostate specific antigen in COVID-19 patients.新冠病毒感染患者中的前列腺特异性抗原
Andrology. 2021 Jul;9(4):1042. doi: 10.1111/andr.12987. Epub 2021 Mar 4.
本文引用的文献
1
COVID-19 Related Anxiety in Men With Localized Prostate Cancer at Tertiary Hospitals in Cape Town, South Africa.南非开普敦三级医院局部前列腺癌男性的 COVID-19 相关焦虑。
Cancer Control. 2021 Jan-Dec;28:10732748211024239. doi: 10.1177/10732748211024239.
2
Evaluating the anxiety and depression status of prostate cancer patients whose operations were postponed because of the COVID-19 pandemic.评估因 COVID-19 大流行而推迟手术的前列腺癌患者的焦虑和抑郁状态。
Int J Clin Pract. 2021 Aug;75(8):e14278. doi: 10.1111/ijcp.14278. Epub 2021 May 26.
Zotero 插件